His therapy has achieved remarkable results, with no tumor growth post-treatment and a disease control rate of 70-80%. His team is now advancing research on cancer vaccines, aiming to initiate ...

Oropharyngeal cancer is a type of head and neck cancer that tends to affect people between 50 and 80 but is becoming more ...

Researchers from Osaka University discover that the GPR31 path in 'gut surveillance' cells detects bacterial metabolites and ...

MUMBAI, (REUTERS) – Adar Poonawalla, CEO of vaccine maker Serum Institute of India, will buy a 50% stake in filmmaker Karan ...

Innovio announced the presentation of new data at scientific conferences for its lead candidate, INO-3107, for which the company is preparing a ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

A 1-dose human papillomavirus (HPV) vaccination program is projected to prevent a similar number of cervical cancers as a 2-dose program.

There are many advancements to talk about during Breast Cancer Awareness Month. Then, a neurologist collaborates with a ...

Cancer vaccines train the immune system to combat foreign invaders like tumours, enhancing the body's ability to recognize ...

A new chemotherapy regimen significantly boosts survival rates in cervical cancer patients and reduces the risk of death by ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...